naproxen
Generic: naproxen
Labeler: aurobindo pharma limitedDrug Facts
Product Profile
Brand Name
naproxen
Generic Name
naproxen
Labeler
aurobindo pharma limited
Dosage Form
SUSPENSION
Routes
Active Ingredients
naproxen 125 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
59651-528
Product ID
59651-528_570974d4-0d5b-4df2-b307-37380511835d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA216504
Listing Expiration
2026-12-31
Marketing Start
2025-10-03
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
59651528
Hyphenated Format
59651-528
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
naproxen (source: ndc)
Generic Name
naproxen (source: ndc)
Application Number
ANDA216504 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 125 mg/5mL
Packaging
- 1 BOTTLE in 1 CARTON (59651-528-47) / 473 mL in 1 BOTTLE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "570974d4-0d5b-4df2-b307-37380511835d", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "upc": ["0359651528471"], "unii": ["57Y76R9ATQ"], "rxcui": ["311913"], "spl_set_id": ["570974d4-0d5b-4df2-b307-37380511835d"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (59651-528-47) / 473 mL in 1 BOTTLE", "package_ndc": "59651-528-47", "marketing_start_date": "20251003"}], "brand_name": "Naproxen", "product_id": "59651-528_570974d4-0d5b-4df2-b307-37380511835d", "dosage_form": "SUSPENSION", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "59651-528", "generic_name": "Naproxen", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naproxen", "active_ingredients": [{"name": "NAPROXEN", "strength": "125 mg/5mL"}], "application_number": "ANDA216504", "marketing_category": "ANDA", "marketing_start_date": "20251003", "listing_expiration_date": "20261231"}